Product Portfolio

The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.

RX

- Prescription Medicines

Medicines available by medical prescription only.

METRONIDAZOL ARENA 500 mg

Antimicrobial and antiparasitic drug, indicated in anaerobic and parasitic infections

Capsules

500 mg

See details

MIRTAZAPIN ARENA 15 mg

Antidepressant drug with noradrenergic and serotonergic action, indicated in the treatment of depression

Film-coated tablets

15 mg

See details

MIRTAZAPIN ARENA 30 mg

Antidepressant drug with noradrenergic and serotonergic action, indicated in the treatment of depression

Film-coated tablets

30 mg

See details

MIRTAZAPIN ARENA 45 mg

Antidepressant drug with noradrenergic and serotonergic action, indicated in the treatment of depression

Film-coated tablets

45 mg

See details

MONTELUKAST ARENA 10 mg

Leukotriene receptor antagonist, indicated in the treatment of asthma and allergic rhinitis

Film-coated tablets

10 mg

See details

MONTELUKAST ARENA 4 mg

Leukotriene receptor antagonist, indicated in the treatment of asthma and allergic rhinitis

Chewable tablets

4 mg

See details

MONTELUKAST ARENA 5 mg

Leukotriene receptor antagonist, indicated in the treatment of asthma and allergic rhinitis

Chewable tablets

5 mg

See details

N-DICLOFENAC 50 mg

Non-steroidal anti-inflammatory drug with strong analgesic (pain-relieving) and antipyretic (fever-reducing) effect

Coated tablets

50 mg

See details

NIMESULIDA ARENA 100 mg

Selective non-steroidal anti-inflammatory drug, with analgesic and antipyretic effect

Tablets

100 mg

See details